ArticleCancer research2009
The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.
Raushan T Kurmasheva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
85 papers cite itlatest 60 shown
this paperpooled ittrialcites it